Director/PDMR shareholding: Disclosure and Transparency Rules 3.1.4R (1) (a)
On 18 May 2016 Jes Staley notified the Company that on 18 May 2016 he had purchased 144,000 American Depositary Shares* ('ADS') of the Company at an average price of $9.95051 per ADS. The transaction took place on the New York Stock Exchange.
Following this transaction, Jes Staley has a total beneficial interest in 3,966,786 ordinary shares in the Company.
*Each American Depositary Share represents four ordinary shares of the Company with a nominal value of 25p each
For further information please contact:
ANALYSTS AND INVESTORS
MEDIA
Kathryn McLeland
Tom Hoskin
+44 (0)20 7116 4943
+44 (0)20 7116 6927
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.